Cas:60469-88-7 ethyl 3,4-dibromobenzoate manufacturer & supplier

We serve Chemical Name:ethyl 3,4-dibromobenzoate CAS:60469-88-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

ethyl 3,4-dibromobenzoate

Chemical Name:ethyl 3,4-dibromobenzoate
CAS.NO:60469-88-7
Synonyms:3,4-dibromo-benzoic acid ethyl ester;3,4-Dibrom-benzoesaeure-aethylester;1,2-dibromo-4-(ethoxycarbonyl)benzene;Ethyl-3,4-dibrombenzoat
Molecular Formula:C9H8Br2O2
Molecular Weight:307.96700
HS Code:2916399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:331.7ºC at 760 mmHg
Density:1.747g/cm3
Index of Refraction:1.572
PSA:26.30000
Exact Mass:305.88900
LogP:3.38830

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3,4-dibromo-benzoic acid ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl-3,4-dibrombenzoat physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2-dibromo-4-(ethoxycarbonyl)benzene Use and application,1,2-dibromo-4-(ethoxycarbonyl)benzene technical grade,usp/ep/jp grade.


Related News: A week after the memo was released to employees, Reuters reported that the Justice Department had launched a criminal investigation focused on the Branchburg plant. That same day, May 27, Lilly reported to the U.S. Securities and Exchange Commission that it had received a subpoena from the department seeking documents related to the factory. ethyl 3,4-dibromobenzoate manufacturer Taiwan complained on Sunday that it was being punished because the World Health Organization considers it part of China, which has been subject to travel bans as the coronavirus spreads. ethyl 3,4-dibromobenzoate supplier China’s basic chemical industry is developed, and the intermediate industry has also entered a mature stage. It is basically able to independently support the production needs of various domestic drug substances, which also brings cost advantages to Chinese drug substance companies. On the other hand, if there is insufficient supply of upstream products or price fluctuations, the sales of API products will also fluctuate in volume and price. ethyl 3,4-dibromobenzoate vendor Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova. ethyl 3,4-dibromobenzoate factory China’s basic chemical industry is developed, and the intermediate industry has also entered a mature stage. It is basically able to independently support the production needs of various domestic drug substances, which also brings cost advantages to Chinese drug substance companies. On the other hand, if there is insufficient supply of upstream products or price fluctuations, the sales of API products will also fluctuate in volume and price.